Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NA
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
PHASE2
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
PHASE3
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
NA
This clinical trial studies fludarabine phosphate and total-body radiation ...
90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
PHASE1
This phase I trial studies the side effects and best dose of yttrium Y 90 a...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
PHASE2
RATIONALE: Drugs used in chemotherapy such as fludarabine use different way...